Transcode Therapeutics RNAZ Cash Flow Statement (2020-2026)

NASDAQ RNAZ
$1.65 +0.02 (+1.23%)
As of: Sep 30, 2026 · 3:51 PM EDT
Reported Financials

Transcode Therapeutics Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Transcode Therapeutics reported cash from operations of -$5.40M and free cash flow of -$5.40M for the quarter ended Jun 2026, down 28.7% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.36M-2.99M-3.48M-4.71M-4.94M-5.49M-4.90M-5.13M-5.33M-4.11M-3.30M-5.12M-2.18M-5.09M-12.09M-4.28M-4.57M-15.95M-17.55M-6.75M
Depreciation and Depletion
0.01M0.03M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.01M0.01M0.01M0.00M0.04M0.02M0.02M
Share-based Compensation
0.06M0.04M0.06M0.10M0.11M0.13M0.16M0.18M0.39M0.31M0.18M1.14M0.20M0.17M0.16M0.13M0.13M0.06M
Cash from Operations
-3.07M-1.60M-3.95M-3.37M-4.42M-4.02M-4.51M-4.39M-3.51M-5.66M-3.94M-2.34M-3.91M-3.15M-3.10M-4.19M-4.11M-8.12M-5.00M-5.40M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.01M0.03M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.01M0.01M0.01M0.00M-0.02M0.02M0.02M
Change in Working Capital
Change in Accured Expenses
1.50M0.52M-0.68M-0.12M2.03M0.61M0.58M-1.74M1.96M-2.09M-0.68M0.91M-1.14M0.58M-0.20M-0.94M1.40M-0.04M1.77M-0.59M
Other Working Capital Changes
2.24M-0.80M-0.12M-1.33M1.84M-0.24M0.67M-1.40M0.45M-0.14M0.11M-0.77M0.36M-0.11M-0.13M-0.46M1.03M-0.91M0.70M0.64M
Investing Activities
Capital Expenditures
0.07M0.09M0.03M0.04M0.03M0.01M0.02M0.00M0.00M0.00M0.01M500.00
Cash from Investing Activities
-0.07M-0.08M-0.03M-0.04M-0.03M-0.01M-0.02M-0.00M-0.00M-0.00M-0.01M-500.00
Financing Activities
Change in Capital Stock
Shares Issued
679.000.04M0.83M0.83M0.92M1.21M1.21M
Net Equity Issued and Repurchased
0.01M1.18M6.50M7.26M0.98M6.09M0.79M2.45M7.08M8.85M13.81M
Misc.
Cash from Financing Activities
25.56M0.01M0.01M-0.23M0.23M1.18M6.36M7.39M0.98M6.09M0.79M2.45M7.08M8.85M-0.46M23.12M
Change in Cash
22.42M-1.67M-3.97M-3.41M-4.65M-3.82M-3.35M1.95M3.88M-4.69M2.15M-1.56M-1.48M3.94M5.76M-4.19M-4.54M14.98M-4.98M-4.45M
Free Cash Flow
-3.14M-1.69M-3.98M-3.41M-4.42M-4.05M-4.53M-4.41M-3.51M-5.66M-3.94M-2.34M-3.93M-3.15M-3.10M-4.19M-4.11M-8.12M-5.00M-5.40M
Net Cash Flow
22.42M-1.67M-3.97M-3.41M-4.65M-3.82M-3.35M1.95M3.88M-4.69M2.15M-1.56M-1.48M3.94M5.76M-4.19M-4.56M15.01M-5.00M-5.40M

Transcode Therapeutics Cash Flow Statement API

Pull Transcode Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RNAZ&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY